Abstract
Chemotherapeutic agents induce p53-dependent apoptosis in the hair follicle (HF) resulting in hair loss, a common side effect of cancer therapy. Here, we show that Fas as a p53 target plays important role in the HF response to cyclophosphamide. Specifically, we demonstrate that Fas is up-regulated in HF keratinocytes after cyclophosphamide treatment, Fas ligand-neutralizing antibody partially inhibits HF response to cyclophosphamide in wild-type mice, and Fas knockout mice show significant retardation of cyclophosphamide-induced HF involution associated with reduced Fas-associated death domain and caspase-8 expression. These data raise a possibility to explore blockade of Fas signaling as a part of complex local therapy for inhibiting keratinocyte apoptosis and hair loss induced by chemotherapy.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adaptor Proteins, Signal Transducing*
-
Animals
-
Antibodies / immunology
-
Antibodies / pharmacology
-
Antineoplastic Agents, Alkylating / pharmacology*
-
Apoptosis / drug effects
-
Carrier Proteins / biosynthesis
-
Caspase 8
-
Caspases / biosynthesis
-
Cyclophosphamide / pharmacology*
-
Fas Ligand Protein
-
Fas-Associated Death Domain Protein
-
Female
-
Hair Follicle / drug effects*
-
Hair Follicle / physiology*
-
In Situ Nick-End Labeling
-
Keratinocytes / cytology
-
Keratinocytes / drug effects
-
Membrane Glycoproteins / antagonists & inhibitors
-
Membrane Glycoproteins / immunology
-
Membrane Glycoproteins / metabolism
-
Mice
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Signal Transduction
-
fas Receptor / metabolism
-
fas Receptor / physiology*
Substances
-
Adaptor Proteins, Signal Transducing
-
Antibodies
-
Antineoplastic Agents, Alkylating
-
Carrier Proteins
-
Fadd protein, mouse
-
Fas Ligand Protein
-
Fas-Associated Death Domain Protein
-
Fasl protein, mouse
-
Membrane Glycoproteins
-
fas Receptor
-
Cyclophosphamide
-
Casp8 protein, mouse
-
Caspase 8
-
Caspases